Arzeda and KENT Specialty Milling Partner on AI Protein Design Collaboration
Arzeda and KENT Specialty Milling have entered a product development collaboration to create new proteins using AI-based design technology, announced in a press release.
The partnership will combine Arzeda's Intelligent Protein Design Technology with KENT's application and market expertise to explore new methods that improve performance and efficiency across target markets. The collaboration is intended to design and validate novel proteins with specific performance characteristics.
Arzeda's platform uses AI-based design, lab testing, and process development to create and manufacture proteins tailored for particular applications. KENT Specialty Milling contributes manufacturing and market knowledge to help move these innovations toward scalable production. Specific technical milestones have not been disclosed.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
AKA Foods Launches Alchemy and Opens Atlas Beta for Food R&D
Standigm and Protai Start AI Molecular Glue Research Program
Arkestro Plans European Expansion as EU Spend Rises 93%
Probably Genetic Gets Up to $10M ARPA-H Contract for Rare Disease AI
Tsingke Introduces Validation Workflow for AI Designed Proteins
Daily AI Brief: the AI news that matters, in your inbox.